Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Kiniksa Pharmaceuticals International, plc (KNSA) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$180.85M |
|
$18.43M |
|
$20.26M |
|
$160.60M |
|
$156.83M |
|
$24.02M |
|
$3.14M |
|
$27.16M |
|
$27.16M |
|
$18.43M |
|
$18.43M |
|
$18.43M |
|
$18.43M |
|
$24.02M |
|
$24.41M |
|
74.72M |
|
80.03M |
|
$0.25 |
|
$0.23 |
|
| Balance Sheet Financials | |
$475.53M |
|
$1.66M |
|
$236.80M |
|
$712.33M |
|
$123.59M |
|
-- |
|
$53.36M |
|
$176.95M |
|
$535.38M |
|
$519.88M |
|
$535.38M |
|
75.42M |
|
| Cash Flow Statement Financials | |
$84.09M |
|
$-118.18M |
|
$25.36M |
|
$183.58M |
|
$174.86M |
|
$-8.72M |
|
$26.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.85 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
88.80% |
|
13.28% |
|
13.28% |
|
-- |
|
15.02% |
|
10.19% |
|
$83.16M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.49 |
|
3.50 |
|
25.75 |
|
3.44% |
|
3.55% |
|
2.59% |
|
3.44% |
|
$7.10 |
|
$1.04 |
|
$1.05 |
|